This meeting formed part of an international consultation process that has identified 10 key
questions relating to the use of corticosteroids and immunosuppressants in inflammatory bowel
disease (IBD). Draft answers, prepared in conjunction with an International Steering Committee,
were the focus of discussion. An invitation extended to all members of the New Zealand Society
of Gastroenterology, brought together 16 gastroenterologists with expertise and interest in the
treatment of IBD.
Download PDF